Plus therapeutics q1 loss per share $0.28 from continuing operations

Plus therapeutics reports first quarter 2020 financial and business results.q1 loss per share $0.28 from continuing operations.ended q1 2020 with approximately $16.1 million of cash and cash equivalents.

pstv Ratings Summary

pstv Quant Ranking